hyperuricemia
Conditions
Interventions
Oral administration of melinjo seed extract powder (300mg/day, 12weeks)
Sponsors
Research Center for Immunological Analysis, Inc.
Eligibility
Sex/Gender
Male
Inclusion criteria
Inclusion criteria: [1] Male subjects whose serum uric acid level is between 7.0 mg/dL and 7.9 mg/dL, and age is between 20 and 69 years old.
Exclusion criteria
Exclusion criteria: [1] Taking drugs that may affect serum uric acid level. [2] Individuals who can't stop taking supplement and functional food that may affect serum uric acid level during the test peripd. [3] Individuals who have an infection needed systemic therapy. [4] Individuals who are considered that participation for this trial is difficult because of psychiatric symptoms or psychosis. [5] Individuals who have a uncontrollable diabetes millutus or requiring administration of insulin. [6] Individuals who are sensitive to test products. [7] AST >150U/L. [8] ALT >150U/L. [9] Total bilirubin >2.0mg/dL. [10] Individuals who have a kidney disease. [11] Individuals who have or had a severe allergy or asthma. [12] Individuals who have a disease needing immediate treatment or serious complication. [13] Individuals with a digestive organ disease or surgical history having an influence on digestive absorption. [14] Individuals who have an anamnesis or a history of present illness of drug dependence or alcohol dependence. [15] Individuals who are participated in another clinical trial that intake/apply any of food, drug, and cosmetics, or willing to be that. [16] Individuals who suffer from gout. [17] Individuals judged inappropriate for participating the study by the principal
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| serum uric acid level (at 2-3 weeks and 1 day before the intervention, and after 4, 8, 12 weeks of daily intake.) | — |
Secondary
| Measure | Time frame |
|---|---|
| blood test, urinalysis (at 2-3 weeks and 1 day before the intervention, and after 4, 8, 12 weeks of daily intake.) | — |
Countries
Japan
Contacts
Public ContactTatsuya Sakamoto
Research Center for Immunological Analysis, Inc. none
Outcome results
None listed